LCM
PBYI icon

Landscape Capital Management’s Puma Biotechnology PBYI Stock Holding History

Landscape Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-9,401
Closed -$289K – 428
2017
Q1 		$289K Hold
9,401
– – 0.03% 399
2016
Q4 		$289K Buy
+9,401
New +$406K 0.04% 428
2016
Q1 		– Sell
-9,375
Closed -$735K – 757
2015
Q4 		$735K Buy
+9,375
New +$736K 0.09% 293

Other funds holding PBYI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Landscape Capital Management's PBYI Position: Q2 2017 in Review

Landscape Capital Management sold out of Puma Biotechnology (PBYI) in Q2 2017, closing a stake of 9,401 shares — an estimated $289K sold.

Landscape Capital Management first reported a position in PBYI in Q4 2015 and held it in 3 quarters. The position peaked at $735K in Q4 2015. 154 funds tracked by Wall St. Rank hold PBYI as of Q2 2017.

  • Landscape Capital Management reported no remaining Puma Biotechnology position as of Q2 2017 after selling out during the quarter.
  • Landscape Capital Management sold 9,401 Puma Biotechnology shares in Q2 2017, an estimated $289K.
  • Landscape Capital Management first reported a position in Puma Biotechnology in Q4 2015 and held it in 3 quarters.
  • Landscape Capital Management's Puma Biotechnology position peaked at $735K in Q4 2015.
  • 154 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2017.

Based on Landscape Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.